miGut-Health Personalised blueprint intestinal health
- Coordinator
- Universitatsklinikum Schleswig-Holstein, Germany
- Runs
- 1 January 2023 to 31 December 2026
- Status
- Running
- EU funding
- €7.1m
- Total cost
- €7.1m
- Partners
- 13 organisations in 10 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101095470
What the project is doing
In the project's own words, from its summary on CORDIS.
The miGut-Health consortium aims to develop a personalized blueprint of intestinal health to predict and prevent inflammatory bowel disease. The overall goal is to deliver interdisciplinary solutions (molecular, nutritional, eHealth and patient engagement/empowerment level) for health promotion and disease prevention that would enable active patient engagement in health and self-care management. Taking on this mission, miGut-Health pursues the following strategic goals:- To integrate state-of-the-art omics (molecular, clinical, nutrition, social and environmental) for identification of actionable biomarkers, risk and health promoting factors linked to health-to-disease transition in the general population, IBD high risk persons, as well as IBD patients.- To perform systems-level analyses of chronic inflammation by applying integrative models from omics and clinical data to predict risk for health-to-disease transition in IBD.- To perform a proof-of-concept controlled clinical trial studying a nutrient elimination diet (here: gluten-free diet) and its impact on intestinal inflammation in IBD patients and high-risk individuals.- To exploit the impact of microbiome-derived diet-associated metabolites on gut inflammation reversion and restoration of barrier integrity and function using an innovative co-culture system of primary human intestinal organoids and sorted immune cell subsets.- To develop and apply novel technologies (sensors, mobile apps) to dynamically monitor individual nutrition as well as physical activity and principal health status.- To implement a patient-centered approach for personalized health and self-care engagement targeted at IBD patients, individuals at risk for IBD and the general population as well as tools for health-care professionals.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universitatsklinikum Schleswig-Holstein | Lübeck | Germany | Coordinator |
| International Federation of Crohn's and Ulcerative Colitis Associations | Bruxelles / Brussel | Belgium | Participant |
| Ecole Polytechnique Federale De Lausanne | Lausanne | Switzerland | Associatedpartner |
| Christian-Albrechts-Universitaet Zu Kiel | Kiel | Germany | Third party |
| Eurice European Research and Project Office GmbH | St Ingbert | Germany | Participant |
| Universitaetsklinikum Hamburg-Eppendorf | Hamburg | Germany | Participant |
| Region Hovedstaden | Hillerod | Denmark | Participant |
| Research and Innovation Services Doo Za Usluge | Zagreb | Croatia | Third party |
| Weizmann Institute of Science | Rehovot | Israel | Participant |
| Universita Cattolica Del Sacro Cuore | Milano | Italy | Participant |
| Lietuvos Sveikatos Mokslu Universitetas | Kaunas | Lithuania | Participant |
| Academisch Ziekenhuis Groningen | Groningen | Netherlands | Participant |
| Orebro University | Orebro | Sweden | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI